Orthofix Intl NV Up 10.23% To $14.33 After Earnings Miss

Wednesday, March 6, 2024 - Orthofix Intl NV (OFIX) reported downside earnings and upside revenues.

Analyst expectations for Orthofix Intl NV earnings per share (EPS) were at a loss of $0.08 per share, with the company missing those estimates with a reported EPS loss of $0.59 per share, leading to a negative surprise of $0.51 per share (-638%). Orthofix Intl NV's earnings were down 69% year-over-year as the firm reported an EPS loss of $0.35 per share in its year-ago quarter. The negative annual growth shows the Healthcare company isn't performing well amid current economic conditions.

Analyst projections for Orthofix Intl NV revenue came in at a consensus of $195.3 million. Fourth-Quarter revenues surpassed estimates for $200.4 million by $5.1 million (3%). The company achieved 64% growth year-over-year compared to the firm's revenue of $122.2 million from the year-ago quarter. The lower earnings growth relative to revenue signals Orthofix Intl NV has not been able to improve its profit margin.

The stock is up 10.23% to $14.33 after the report.

The firm's higher revenue growth to earnings signals that the firm has not been able to reduce costs and has seen its profit margin decrease.

The average recommendation from Wall Street analysts was a Buy which may get revised based on this new data.

Trading in the five days leading up to the report earned Orthofix Intl NV a Bearish Sentiment Rank from InvestorsObserver.

Prior to the report, InvestorsObserver gave the stock an overall score of 38. Meanwhile, the average Wall Street analyst rated the stock a Buy.

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.